Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Lymphoid 1

Conditions

Venous Thromboembolism 2Venous Thrombosis 1Thrombosis 1Sarcoma 1Pulmonary Embolism 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Fractures, Spontaneous 1Femoral Fractures 1Bone Neoplasms 1

Interventions

Radiosurgery 23Magnetic Resonance Spectroscopy 13Radiotherapy 9Cryosurgery 9Blood Specimen Collection 9Standard of Care 8Surveys and Questionnaires 7Educational Status 7Surgical Procedures, Operative 6Drug Therapy 6Radiotherapy, Intensity-Modulated 5Palliative Care 5Methods 5Radiofrequency Ablation 4Practice Guidelines as Topic 4Everolimus 4Early Intervention, Educational 4Interviews as Topic 3Exercise Therapy 3Cryotherapy 3Androgen Antagonists 3Zoledronic Acid 2Videotape Recording 2Trastuzumab 2Radiation 2Physical Therapy Modalities 2Patient Navigation 2Misoprostol 2Manual Lymphatic Drainage 2Liver Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Neoplasm Metastasis × Dalteparin × Clear all
NCT00525057 2021-01-22

Dalteparin in Preventing DVT in Participants With Cancer

M.D. Anderson Cancer Center

Phase NA Completed
65 enrolled 14 charts
LymphoidPlasma cellSarcoma

Bone Neoplasms, Femoral Fractures, Fractures, Spontaneous, Lymphoma, Multiple Myeloma, Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡